Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 363, doi. 10.1002/pros.20887
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2009 AND VI 69 AND IP 4
Results: 12
1
2
Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 392, doi. 10.1002/pros.20893
- By:
- Publication type:
- Article
3
Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 373, doi. 10.1002/pros.20886
- By:
- Publication type:
- Article
4
Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 428, doi. 10.1002/pros.20897
- By:
- Publication type:
- Article
5
The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 443, doi. 10.1002/pros.20892
- By:
- Publication type:
- Article
6
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 419, doi. 10.1002/pros.20908
- By:
- Publication type:
- Article
7
Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 352, doi. 10.1002/pros.20889
- By:
- Publication type:
- Article
8
Genome-wide linkage scan for prostate cancer susceptibility from the university of michigan prostate cancer genetics project: Suggestive evidence for linkage at 16q23.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 385, doi. 10.1002/pros.20891
- By:
- Publication type:
- Article
9
Her2 crosstalks with TrkA in a subset of prostate cancer cells: Rationale for a guided dual treatment.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 337, doi. 10.1002/pros.20884
- By:
- Publication type:
- Article
10
Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 401, doi. 10.1002/pros.20895
- By:
- Publication type:
- Article
11
Identification of extracellular δ-catenin accumulation for prostate cancer detection.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 411, doi. 10.1002/pros.20902
- By:
- Publication type:
- Article
12
Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.
- Published in:
- Prostate, 2009, v. 69, n. 4, p. 346, doi. 10.1002/pros.20890
- By:
- Publication type:
- Article